or Try an Advanced Search...

    Technical Analysis for CMMB - ChemomAb Therapeutics Ltd.

    Grade Last Price % Change Price Change
    B 0.97 5.86% 0.05
    CMMB closed up 5.86 percent on Monday, July 1, 2024, on 33 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CMMB trend table...
    Date Alert Name Type % Chg
    180 Bullish Setup Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.86%
    Wide Bands Range Expansion 5.86%
    Down 3 Days in a Row Weakness 5.86%
    Wide Bands Range Expansion -0.51%
    NR7 Range Contraction -3.40%
    Narrow Range Bar Range Contraction -3.40%
    Older End-of-Day Signals for CMMB ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    10 DMA Resistance about 10 hours ago
    2x Volume Pace about 10 hours ago
    1.5x Volume Pace about 10 hours ago
    Up 5% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CMMB Chart by TradingView
    Basic chart:

    Profile

    ChemomAb Ltd. develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases. The company is based in Tel Aviv, Israel.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Immunology Antibodies Monoclonal Antibody Autoimmunity Autoimmune And Inflammatory Disease

    Is CMMB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 18 Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis
    Jun 6 Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference
    May 17 Chemomab Therapeutics to Participate in Upcoming Scientific Conferences
    May 9 Chemomab Therapeutics GAAP EPS of $0.01 beats by $0.02
    May 9 Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
    May 8 Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
    May 2 Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
    Apr 24 Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
    Apr 18 Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
    Apr 2 Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
    See more CMMB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.5
    52 Week Low 0.42
    Average Volume 114,985
    200-Day Moving Average 0.74
    50-Day Moving Average 0.90
    20-Day Moving Average 1.04
    10-Day Moving Average 0.95
    Average True Range 0.11
    RSI (14) 49.49
    ADX 18.79
    +DI 19.84
    -DI 22.55
    Chandelier Exit (Long, 3 ATRs) 1.04
    Chandelier Exit (Short, 3 ATRs) 1.11
    Upper Bollinger Bands 1.27
    Lower Bollinger Band 0.81
    Percent B (%b) 0.34
    BandWidth 44.70
    MACD Line 0.01
    MACD Signal Line 0.02
    MACD Histogram -0.0179
    Fundamentals Value
    Market Cap 10.87 Million
    Num Shares 11.3 Million
    EPS -2.94
    Price-to-Earnings (P/E) Ratio -0.33
    Price-to-Sales 0.00
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.07
    Resistance 3 (R3) 1.06 1.02 1.05
    Resistance 2 (R2) 1.02 0.99 1.02 1.04
    Resistance 1 (R1) 0.99 0.98 1.01 1.00 1.04
    Pivot Point 0.95 0.95 0.96 0.96 0.95
    Support 1 (S1) 0.93 0.93 0.94 0.93 0.89
    Support 2 (S2) 0.89 0.91 0.89 0.89
    Support 3 (S3) 0.86 0.89 0.88
    Support 4 (S4) 0.86